Department of Surgery, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
Division of Plastic Surgery, Faculty of Medicine, Dalhousie University, Halifax, Canada.
Aesthetic Plast Surg. 2022 Apr;46(2):597-609. doi: 10.1007/s00266-021-02664-y. Epub 2021 Nov 29.
Autologous flaps may have superior outcomes when compared to implant breast reconstruction in patients with obesity. To date, no published review has illustrated the superiority of autologous to implant-based reconstruction in this study group in terms of aesthetics outcomes and surgical complications.
A systematic search was conducted on PubMed, Cochrane, Google Scholar, and Embase from inception to December 31, 2020. Studies comparing the outcomes (patient satisfaction and complications) of autologous versus implant-based reconstruction in patients with BMI > 30 were selected.
The search yielded 1633 articles, of which 76 were assessed in full text. A total of 12 articles fit inclusion for qualitative review; of them, 7 were meta-analyzed. Autologous reconstruction had a lower incidence of infection (OR 0.74 [95% CI 0.59, 0.92]), hematoma/seroma formation (OR 0.34 [95% CI 0.23, 0.49]), and reconstructive failure (OR 0.47 [95% CI 0.36, 0.62]), but not skin necrosis (OR 0.95 [95% CI 0.73, 1.25]) or wound dehiscence (OR 1.03 [95% CI 0.72, 1.49]) when compared to implant-based reconstruction. Deep vein thrombosis (DVT) and pulmonary embolism occurred more frequently with autologous versus alloplastic reconstruction (OR 2.21 [95% CI 1.09, 4.49] for DVT and OR 2.49 [95% CI 1.13, 5.48] for PE). BREASTQ scores were higher for the autologous breast reconstruction when compared to implant-based group, but failed to reach significance (p value >0.05).
The current evidence in the literature suggests that autologous breast reconstruction has lower surgical complication rate when compared to implant-based reconstruction at the expense of higher risk of thrombotic complications for patients with BMI > 30.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
与植入物乳房重建相比,自体皮瓣在肥胖患者中可能具有更好的效果。迄今为止,尚无文献综述表明在该研究组中,自体皮瓣在美学效果和手术并发症方面优于植入物重建。
从 2020 年 1 月 1 日至 12 月 31 日,在 PubMed、Cochrane、Google Scholar 和 Embase 上进行了系统搜索。选择了比较 BMI>30 的患者中自体与基于植入物的重建的结果(患者满意度和并发症)的研究。
搜索结果为 1633 篇文章,其中 76 篇进行了全文评估。共有 12 篇文章符合定性综述的纳入标准;其中 7 篇进行了荟萃分析。自体重建的感染发生率较低(OR0.74[95%CI0.59,0.92])、血肿/血清肿形成率较低(OR0.34[95%CI0.23,0.49])和重建失败率较低(OR0.47[95%CI0.36,0.62]),但皮肤坏死率(OR0.95[95%CI0.73,1.25])和伤口裂开率(OR1.03[95%CI0.72,1.49])与基于植入物的重建相似。与全假体重建相比,自体与全假体重建更常发生深静脉血栓形成(DVT)和肺栓塞(OR2.21[95%CI1.09,4.49]为 DVT,OR2.49[95%CI1.13,5.48]为 PE)。与基于植入物的重建组相比,自体乳房重建的 BREASTQ 评分更高,但未达到显著性差异(p 值>0.05)。
目前文献中的证据表明,与基于植入物的重建相比,自体乳房重建的手术并发症发生率较低,但 BMI>30 的患者发生血栓并发症的风险较高。
证据水平 III:本杂志要求作者为每篇文章分配一个证据水平。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南 www.springer.com/00266 。